InsilicoTrials

Stand: 37
InSilicoTrials is an FDA- and EMA-aligned AI company generating regulatory-compliant evidence through advanced in silico methodologies. Our platform combines simulation, predictive intelligence, and digital twins to accelerate the entire drug development lifecycle, from discovery to clinical trials and commercialization. By enabling virtual patients, optimized protocols, and data-driven decision making, we help biotech and pharma reduce risk, accelerate timelines, and significantly cut R&D costs.
Loading

Contact Exhibitor